Clinical Trial Update: Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of Asunaprevir in patients with kidney disease has completed. The trial was sponsored by Bristol-Myers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED